#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Stuart Byham Email
Sr. Director, Clinical Development and Operations . Maia Biotechnology
Chicago, IL
LocationPrimary Email
How to contact Stuart Byham
Join and see Stuart's contact info for free!Phone
Current Roles
Employees:
31Revenue:
$4.8MAbout
MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A privately-held company based in Chicago, MAIA is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into trials in humans clinical trials. MAIA's business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA's business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.Maia Biotechnology Address
444 West Lake StreetChicago, IL
United States